Project I A significant discovery made during the current cycle of this PPG was that effectiveness of anesthetic cardioprotection becomes attenuated in diabetic animals or in hyperglycemic conditions. We have now developed a clinically relevant model of anesthetic cardioprotection using human cardiomyocytes derived from induced pluripotent stem cells, obtained from both non-diabetic and type 2 diabetic patients. This in vitro model of human disease will enable developmental and comparative studies of normal and diabetic cardiomyocytes to address cellular and environmental mechanisms responsible for attenuation of cardioprotection efficacy in diabetics. The working hypothesis is that diabetes-related conditions increase vulnerability to stress through acute and progressive actions on mitochondria and that our strategies can reverse this diabetic phenotype. On the basis of our progress and exciting preliminary data: 1. We will determine anesthetic-induced alterations of mitochondrial bioenergetics and Ca2+ homeostasis in human ventricular cardiomyocytes (Aim 1); 2. Investigate the role of mitochondrial fission and reactive oxygen species during glucolipotoxicity (Aim 2) and; 3. Restore anesthetic cardioprotection during glucolipotoxicity in vitro and in the animal model of diabetes using pharmacological strategies (Aim 3). In summary, the cellular and molecular mechanisms that abolish volatile anesthetic cardioprotection in the diabetic heart are unknown and there are no known treatments to reverse this effect. We will focus our efforts on examination of the signaling and mitochondrial mechanisms in non-diabetic and type 2 diabetic patient-derived cardiomyocytes. Our studies will provide novel mechanistic information on the role of mitochondria and important signaling pathways that modulate cardioprotection in diabetes, and expand on the reversal of diabetic phenotype by attenuation of mitochondrial fission and reversal of nitric oxide synthase uncoupling that will be tested in a diabetic animal model.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Medical College of Wisconsin
United States
Zip Code
Pant, Tarun; Dhanasekaran, Anuradha; Fang, Juan et al. (2018) Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord 18:197
Ge, Zhi-Dong; Li, Yingchuan; Qiao, Shigang et al. (2018) Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I. Anesthesiology 128:117-129
Williams, Anna Marie; Liu, Yong; Regner, Kevin R et al. (2018) Artificial intelligence, physiological genomics, and precision medicine. Physiol Genomics 50:237-243
Liu, Pengyuan; Liu, Yong; Liu, Han et al. (2018) Role of DNA De Novo (De)Methylation in the Kidney in Salt-Induced Hypertension. Hypertension 72:1160-1171
Chuppa, Sandra; Liang, Mingyu; Liu, Pengyuan et al. (2018) MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4. Kidney Int 93:375-389
Korman, Ben; Dash, Ranjan K; Peyton, Philip J (2018) Can Mathematical Modeling Explain the Measured Magnitude of the Second Gas Effect? Anesthesiology 128:1075-1083
Liu, Yong; Usa, Kristie; Wang, Feng et al. (2018) MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension. J Am Soc Nephrol 29:2518-2528
Zhang, Xiao; Dash, Ranjan K; Jacobs, Elizabeth R et al. (2018) Integrated computational model of the bioenergetics of isolated lung mitochondria. PLoS One 13:e0197921
Ghanian, Zahra; Konduri, Girija Ganesh; Audi, Said Halim et al. (2018) Quantitative optical measurement of mitochondrial superoxide dynamics in pulmonary artery endothelial cells. J Innov Opt Health Sci 11:
Liang, Mingyu (2018) Epigenetic Mechanisms and Hypertension. Hypertension 72:1244-1254

Showing the most recent 10 out of 134 publications